New permanent pacemaker (PPM) within 30 days of transcatheter aortic valve replacement (TAVR), remains a frequent complication in patients with aortic stenosis (AS), with identifiable clinical, electrocardiogram (ECG) and imaging predictors. However, new PPM is not associated with worse 5-year clinical outcomes, including mortality, reports a new analysis of registry data.